Approximate combined value of Projects in progress (in €)
0

PRELUDIUM 21 – Modeling the structure of glycerol polyesters depending on the process parameters

Elevating the Future of Cancer care with Alpha Theranostics

Purchase of ICP-MS spectrometer for analysis of radiopharmaceuticals

Modernization of spaces of ICP spectrometry laboratory

Standardisation of the procedure for the preparation and quality control of [177Lu]Lu-PSMA-D4, a radioligand for the treatment of metastatic prostate cancer

AlphaMet - Metrology for emerging targeted alpha therapies

Opus 25 - New biopolymer-based radioisotope nanocarriers for melanoma theranostics, synthesised by radiation technique

EuroNanoMed 3 - Imaging and Inhibitor Probe for Alzheimer's disease Diagnostic and Treatment

PREMIA NA HORYZONCIE 2

SINFONIA - Radiation risk appraisal for detrimental effects from medical exposure during management of patients with lymphoma or brain tumour

PREMIA NA HORYZONCIE 2

PRISMAP - The Euro­pean medi­cal iso­tope pro­gramme: Pro­duc­tion of high purity iso­to­pes by mass sepa­ra­tion

SECURE - Strengthening the European Chain of sUpply for next generation medical RadionuclidEs

PRISMAP - The Euro­pean medi­cal iso­tope pro­gramme: Pro­duc­tion of high purity iso­to­pes by mass sepa­ra­tion

SINFONIA - Radiation risk appraisal for detrimental effects from medical exposure during management of patients with lymphoma or brain tumour

DuoNen - Tandem therapy LutaPol/ItraPol (177Lu / 90Y-DOTATATE) as an effective method in the treatment of neuroendocrine neoplasmas

CERAD - Centre for Design and Synthesis of Molecularly Targeted Radiopharmaceuticals

Learn more about Projects completed